ClinicalTrials.Veeva

Menu
Keralty Hospital Miami | Keralty Research Center logo

Keralty Hospital Miami | Keralty Research Center

Research site

Site insights

Top conditions

Top treatments

RDV
Palmitoylethanolamide
Niclosamide
TV-44749
Pomotrelvir
PEA
PBI-0451
APL-9
NP-120
Baricitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Maria T Bertoli

Verified by this site

Active trials

4 of 13 total trials

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia (SOLARIS)

The primary objective of this study is to evaluate the efficacy of TV-44749 in adult participants with schizophrenia.A key secondary objective is to...

Active, not recruiting
Schizophrenia
Drug: TV-44749 - Dose level 3
Drug: Placebo

The purpose of this study is to compare CHF 5993 with CHF 1535 in improving lung function, reducing moderate and severe COPD exacerbations, and other...

Enrolling
COPD
COPD Exacerbation
Drug: Beclomethasone Dipropionate
Drug: Formoterol Fumarate
Locations recently updated

The primary purpose of this study is to assess the long-term safety and tolerability of oral emraclidine in adult participants with schizophrenia.

Enrolling
Schizophrenia
Drug: CVL-231 30 mg

TP-102 is a novel bacteriophage cocktail comprised of 5 (five) lytic bacteriophages against Staphylococcus aureus, Pseudomonas aeruginosa, and Acinet...

Enrolling
Diabetic Foot Infection
Biological: TP-102
Other: Placebo

Trial sponsors

A
A
Cerevel Therapeutics logo
Chiesi logo
F
Gilead Sciences logo
Lilly logo
P
Romark Laboratories logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems